Crystalvue Medical Corporation (TPEX:6527)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
77.00
+2.50 (3.36%)
At close: Mar 6, 2026
Market Cap1.95B -8.4%
Revenue (ttm)949.05M +9.3%
Net Income146.98M +15.6%
EPS5.70 +15.2%
Shares Out25.34M
PE Ratio13.51
Forward PEn/a
Dividend2.25 (3.02%)
Ex-Dividend DateJul 24, 2025
Volume5,713
Average Volume15,248
Open75.00
Previous Close74.50
Day's Range75.00 - 77.00
52-Week Range68.60 - 93.00
Beta0.89
RSI56.47
Earnings DateMar 3, 2026

About Crystalvue Medical

Crystalvue Medical Corporation designs, produces, and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan. [Read more]

Sector Healthcare
Founded 2009
Employees 109
Stock Exchange Taipei Exchange
Ticker Symbol 6527
Full Company Profile

Financial Performance

In 2025, Crystalvue Medical's revenue was 949.05 million, an increase of 9.33% compared to the previous year's 868.03 million. Earnings were 146.98 million, an increase of 15.59%.

Financial Statements